%0 Journal Article %J Am J Hematol %D 2019 %T Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry. %A Farruggia, Piero %A Fioredda, Francesca %A Puccio, Giuseppe %A Onofrillo, Daniela %A Russo, Giovanna %A Barone, Angelica %A Bonanomi, Sonia %A Boscarol, Gianluca %A Finocchi, Andrea %A Ghilardi, Roberta %A Giordano, Paola %A Ladogana, Saverio %A Lassandro, Giuseppe %A Luti, Laura %A Lanza, Tiziana %A Mandaglio, Rosalba %A Marra, Nicoletta %A Martire, Baldassare %A Mastrodicasa, Elena %A Motta, Milena %A Notarangelo, Lucia Dora %A Pillon, Marta %A Porretti, Laura %A Serafinelli, Jessica %A Trizzino, Angela %A Tucci, Fabio %A Veltroni, Marinella %A Verzegnassi, Federico %A Ramenghi, Ugo %A Dufour, Carlo %X

Autoimmune neutropenia of infancy (AIN) is characterized by low risk of severe infection, tendency to spontaneously resolve and typically onset at ≤4-5 years of age; it is due to auto-antibodies whose detection is often difficult. In case of negativity of 4 antineutrophils autoantibody tests, after having excluded ethnic, postinfection, drug induced, or congenital neutropenia, according to the Italian guidelines the patients will be defined as affected by "idiopathic neutropenia" (IN). We describe the characteristics of 85 IN patients enrolled in the Italian neutropenia registry: they were compared with 336 children affected by AIN. The 2 groups were clinically very similar and the main differences were detection age (later in IN), length of disease (longer in IN) and, among recovered patients, age of spontaneous recovery: the median age at resolution was 2.13 years in AINs and 3.03 years in INs (P = .00002). At bivariate analysis among AIN patients earlier detection age (P = .00013), male sex (P = .000748), absence of leucopenia (P = .0045), and absence of monocytosis (P = .0419) were significantly associated with earlier recovery; in the IN group only detection age (P = .013) and absence of monocytosis (P = .0333) were significant. At multivariate analysis detection age and absence of monocytosis were independently significant (P = 6.7e-05 and 4.4e-03, respectively) in the AIN group, whereas in the IN group only detection age stayed significant (P = .013).

%B Am J Hematol %V 94 %P 216-222 %8 2019 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/30456824?dopt=Abstract %R 10.1002/ajh.25353 %0 Journal Article %J Am J Hematol %D 2017 %T Autoimmune neutropenia of childhood secondary to other autoimmune disorders: Data from the Italian neutropenia registry. %A Farruggia, Piero %A Puccio, Giuseppe %A Fioredda, Francesca %A Lanza, Tiziana %A Porretti, Laura %A Ramenghi, Ugo %A Barone, Angelica %A Bonanomi, Sonia %A Finocchi, Andrea %A Ghilardi, Roberta %A Ladogana, Saverio %A Marra, Nicoletta %A Martire, Baldassare %A Notarangelo, Lucia Dora %A Onofrillo, Daniela %A Pillon, Marta %A Russo, Giovanna %A Lo Valvo, Laura %A Serafinelli, Jessica %A Tucci, Fabio %A Zunica, Fiammetta %A Verzegnassi, Federico %A Dufour, Carlo %K Autoimmune Diseases %K Child %K Disease Susceptibility %K Female %K Humans %K Immunoglobulins, Intravenous %K Immunosuppressive Agents %K Infant, Newborn %K Infant, Premature %K Infant, Premature, Diseases %K Italy %K Male %K Neutropenia %K Prevalence %K Registries %B Am J Hematol %V 92 %P E546-E549 %8 2017 Sep %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/28567966?dopt=Abstract %R 10.1002/ajh.24803 %0 Journal Article %J Am J Hematol %D 2016 %T Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Associ %A Svahn, Johanna %A Bagnasco, Francesca %A Cappelli, Enrico %A Onofrillo, Daniela %A Caruso, Silvia %A Corsolini, Fabio %A De Rocco, Daniela %A Savoia, Anna %A Longoni, Daniela %A Pillon, Marta %A Marra, Nicoletta %A Ramenghi, Ugo %A Farruggia, Piero %A Locasciulli, Anna %A Addari, Carmen %A Cerri, Carla %A Mastrodicasa, Elena %A Casazza, Gabriella %A Verzegnassi, Federico %A Riccardi, Francesca %A Haupt, Riccardo %A Barone, Angelica %A Cesaro, Simone %A Cugno, Chiara %A Dufour, Carlo %X

We analyzed 97 Fanconi anemia patients from a clinic/biological database for genotype, somatic, and hematologic phenotype, adverse hematological events, solid tumors, and treatment. Seventy-two patients belonged to complementation group A. Eighty percent of patients presented with mild/moderate somatic phenotype and most with cytopenia. No correlation was seen between somatic/hematologic phenotype and number of missense mutations of FANCA alleles. Over follow-up, 33% of patients improved or maintained mild/moderate cytopenia or normal blood count, whereas remaining worsened cytopenia. Eleven patients developed a hematological adverse event (MDS, AML, pathological cytogenetics) and three developed solid tumors. 10 years cumulative risk of death of the whole cohort was 25.6% with median follow-up 5.8 years. In patients eligible to hematopoietic stem cell transplantation because of moderate cytopenia, mortality was significantly higher in subjects transplanted from matched unrelated donor over nontransplanted subjects, whereas there was no significant difference between matched sibling donor transplants and nontransplanted patients. In patients eligible to transplant because of severe cytopenia and clonal disease, mortality risk was not significantly different in transplanted from matched unrelated versus matched sibling donor versus nontransplanted subjects. The decision to transplant should rely on various elements including, type of donor, HLA matching, patient comorbidities, impairment, and clonal evolution of hematopoiesis. Am. J. Hematol. 91:666-671, 2016. © 2016 Wiley Periodicals, Inc.

%B Am J Hematol %V 91 %P 666-71 %8 2016 Jul %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/27013026?dopt=Abstract %R 10.1002/ajh.24373